By Clinical Research News Staff

September 22, 2026 | Last week, Condor launched a new clinical finance agent that gives R&D teams the "why" behind variances, runs full what-if scenario planning, and then builds the resulting model directly in Condor. It's part of a team of agents built on Condor's clinical and financial ontology and knowledge graph with the Big 4 accounting and consulting firms. The agents automate workflows so R&D teams can make clinical and financial decisions more quickly and confidently.

While AI has accelerated drug discovery and increased the number of viable candidates, the financial infrastructure drug development runs on remains remarkably manual and labor intensive. When a budget, forecast, and actuals diverge, R&D teams can lose hours, if not days, reconciling data across ERPs, CTMS, EDC systems, and spreadsheets to better understand the financial impact behind the "why". Lagging decisions have real consequences — like continuing to fund an underperforming site, discovering a change-order problem after negotiations are already underway, or waiting weeks to understand the financial implications of an enrollment change.

The clinical finance agent reasons across an organization's full budget and forecast history in Condor to explain the "why" behind the numbers, identifying in seconds rather than hours what's driving a variance between actuals and forecast or the cost to complete a given trial. It also runs full what-if scenario planning, modeling changes to site mix, enrollment timing, or financial investment, and then builds the resulting model directly in the platform. Powered by Condor's proprietary knowledge graph and a deterministic math layer with AI reasoning on top, the agent is tuned to how R&D teams actually ask questions; not generic corporate forecasting logic. Additionally capabilities will be added to the agent soon.

Here's how the agent works: you ask the questions that used to take your team weeks to prepare and instantly get answers you can act on. For example, a clinical operations team or finance leader can ask:

"Which sites in this trial are falling behind, and what does that mean for my budget, timeline, and enrollment?" Condor identifies the sites creating risk and connects their performance to the downstream impact on enrollment, timing, and cost.

 "What will it cost to complete enrollment?" Condor calculates a cost-to-complete forecast based on the current state of the trial, without waiting weeks for a team to manually rebuild the model.

"Why did my change order increase?" Condor traces the increase back to the clinical and operational activity driving it and identifies where there may be an opportunity to reduce the cost.

The clinical finance agent is one of several agents in Condor AI Workflows, one of Condor's three product pillars. Condor Connect automatically centralizes clinical, operational, and financial data with an understanding of a biopharma's processes. Condor AI Workflows then automates various workflows, like budgeting, forecasts, month-end closes, accruals, and change order management. Condor AI Insights then surfaces patterns, flags risks, bridges context across functions, and delivers the "why" behind the numbers.